10/03/2024
Gammora is an innovative HIV medication designed to disrupt viral replication by inducing programmed cell death specifically in HIV-infected cells, while sparing healthy ones. By targeting key cellular components involved in viral replication, Gammora triggers the self-destruction of infected cells, thereby reducing the overall viral load in the body. This targeted approach holds promise for addressing drug-resistant HIV strains and slowing disease progression. Clinical trials have shown encouraging efficacy and safety profiles, suggesting Gammora could complement existing antiretroviral therapies in managing HIV/AIDS.
